Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt Issuances
Ratios

Groove Botanicals (GRVE) EBIAT (2016 - 2017)

Groove Botanicals' EBIAT history spans 8 years, with the latest figure at -$58255.0 for Q1 2017.

  • For Q1 2017, EBIAT rose 97.57% year-over-year to -$58255.0; the TTM value through Mar 2017 reached -$243193.0, up 90.29%, while the annual FY2025 figure was -$130834.0, 35.26% up from the prior year.
  • EBIAT for Q1 2017 was -$58255.0 at Groove Botanicals, up from -$124294.0 in the prior quarter.
  • Across five years, EBIAT topped out at $30.0 million in Q1 2013 and bottomed at -$2.4 million in Q1 2016.
  • The 5-year median for EBIAT is -$116374.0 (2014), against an average of $1.6 million.
  • The largest annual shift saw EBIAT soared 14230.33% in 2013 before it plummeted 1243.36% in 2016.
  • A 5-year view of EBIAT shows it stood at -$158601.0 in 2013, then skyrocketed by 169.34% to $109977.0 in 2014, then crashed by 217.65% to -$129385.0 in 2015, then grew by 3.93% to -$124294.0 in 2016, then skyrocketed by 53.13% to -$58255.0 in 2017.
  • Per Business Quant, the three most recent readings for GRVE's EBIAT are -$58255.0 (Q1 2017), -$124294.0 (Q4 2016), and -$28369.0 (Q3 2016).